🕵️ Bioxytran, Inc ($BIXT)
SEC insider & ownership activity, last 12 months · CIK 1445815 · every row links its SEC filing
Over the last 12 months insiders bought $126K with no open-market selling against it. Alan M. Hoberman bought $126K in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $126K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Alan M. Hoberman | 1 | $126K | 0 | – | Nov 18, 2025 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Unregistered equity sale (3.02) | Mar 20, 2026 | filing ↗ |
| Other events (8.01) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 12, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Other events (8.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 10, 2026 | filing ↗ |
| Other events (8.01) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 29, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 7, 2025 | filing ↗ |